SCHEMBL2390480

SCHEMBL2390480

CCCCCCCCCCCCOCC(CO)OC(CO)COCCCCCCCCCCCC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.66
HTT P42858 2/20 0.53
MEN1 O00255 1/20 0.52
THRB P10828 1/20 0.52
KMT2A Q03164 1/20 0.52
MAPT P10636 1/20 0.52
LPAR1 Q92633 7/20 0.50
LPAR3 Q9UBY5 7/20 0.50
LPAR2 Q9HBW0 4/20 0.50
LPAR5 Q9H1C0 4/20 0.50
LPAR6 P43657 3/20 0.50
LPAR4 Q99677 3/20 0.50
SPHK1 Q9NYA1 1/20 0.49
PRKD3 O94806 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
PRKCA P17252 1/20 0.47
PRKCH P24723 1/20 0.47
PRKCI P41743 1/20 0.47
PRKCE Q02156 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6428917 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL9081739 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL3422793 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL6431402 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL15412325 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL6429702 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL16004728 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL6429539 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL15412716 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A
SCHEMBL6428812 1.00 USP2 (0.66) USP2HTTMEN1THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107106663-B Compositions and kits for enzymatic debridement and methods of use thereof 罗查尔科技有限责任公司 2022-12-06 CN claimed
EP-2594248-B1 Active ingredient combination and use thereof Air Liquide Santé (International) (FR) 2016-12-14 EP claimed
EP-1683416-B1 Alcoholic compositions for disinfection AIR LIQUIDE SANTÉ INTERNATIONAL (FR) 2015-12-09 EP claimed
CN-107106663-B Compositions and kits for enzymatic debridement and methods of use thereof 罗查尔科技有限责任公司 2022-12-06 CN disclosed
EP-1683416-B1 Alcoholic compositions for disinfection AIR LIQUIDE SANTÉ INTERNATIONAL (FR) 2015-12-09 EP disclosed
US-8912365-B2 Process for preparing a polyol ether FONDS DE DEVELOPPEMENT DES FILIERES DES OLEAGINEUX ET PROTEAGINEUX FIDOP (FR) 2014-12-16 US disclosed
US-20140018579-A1 PROCESS FOR PREPARING A POLYOL ETHER CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2014-01-16 US disclosed
US-20110237626-A1 COMPOSITIONS FOR HYGIENIC HAND DISINFECTION AND DISINFECTANT HANDWASHING AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2011-09-29 US disclosed
US-20060165612-A1 Compositions for hygienic hand disinfection and disinfectant handwashing AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2006-07-27 US disclosed
EP-1683416-A1 Alcoholic compositions for disinfection Air Liquide Santé (International) (FR) 2006-07-26 EP disclosed
EP-1683417-A1 Disinfectant composition including glycerol monoalkyl ethers and bispyridiniumalkanes and use as skin antiseptic. Air Liquide Santé (International) (FR) 2006-07-26 EP disclosed
EP-1683418-A1 Compositions for hygienic hand disinfection and disinfectant handwashing Air Liquide Santé (International) (FR) 2006-07-26 EP disclosed
US-20060159647-A1 Compositions for hygienic hand disinfection and disinfectant handwashing AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2006-07-20 US disclosed
US-20050043402-A1 Methods and formulations for counteracting infection of mucosa or skin LIPOMEDICA EHF. (IS) 2005-02-24 US disclosed
US-6596763-B1 Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous LIPOMEDICA EHF. (IS) 2003-07-22 US disclosed
EP-0941087-A1 TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS Thormar, Halldor (IS) 1999-09-15 EP disclosed
WO-1998020872-A1 TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS THORMAR HALLDOR (IS) 1998-05-22 WO disclosed
WO-1996035663-A1 OLIGOMERIC ALKYL ETHER SULPHATES AND USE THEREOF IN CLEANING COMPOSITIONS RHONE-POULENC CHIMIE (FR) 1996-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060159647-A1 Compositions for hygienic hand disinfection and disinfectant handwashing DHCR24, DEGS1, ADH1C USP2 279/4885HTT 1984/4885MEN1 3076/4885
US-20140018579-A1 PROCESS FOR PREPARING A POLYOL ETHER RER1, CYP2F1, CYP2E1 USP2 1337/4885HTT 4499/4885MEN1 819/4885
US-20050043402-A1 Methods and formulations for counteracting infection of mucosa or skin MGLL, GK, UGCG USP2 1597/4885HTT 3992/4885MEN1 1080/4885
US-20110237626-A1 COMPOSITIONS FOR HYGIENIC HAND DISINFECTION AND DISINFECTANT HANDWASHING DHCR24, DEGS1, ADH1C USP2 279/4885HTT 1984/4885MEN1 3076/4885
US-20060165612-A1 Compositions for hygienic hand disinfection and disinfectant handwashing PIK3C3, POLR1C, CUTA USP2 170/4885HTT 1325/4885MEN1 3601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.